Gates Biomanufacturing Facility Revenue and Competitors
Estimated Revenue & Valuation
- Gates Biomanufacturing Facility's estimated annual revenue is currently $9.1M per year.
- Gates Biomanufacturing Facility's estimated revenue per employee is $155,000
Employee Data
- Gates Biomanufacturing Facility has 59 Employees.
- Gates Biomanufacturing Facility grew their employee count by 0% last year.
Gates Biomanufacturing Facility's People
Name | Title | Email/Phone |
---|
Gates Biomanufacturing Facility Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $2.8M | 18 | 13% | N/A | N/A |
#3 | $70.2M | 453 | -1% | N/A | N/A |
#4 | $1.6M | 10 | -66% | N/A | N/A |
#5 | $3.7M | 24 | -8% | N/A | N/A |
#6 | $2.9M | 37 | 28% | N/A | N/A |
#7 | $3.1M | 20 | 25% | N/A | N/A |
#8 | $2.5M | 16 | -20% | N/A | N/A |
#9 | $9.1M | 59 | 0% | N/A | N/A |
#10 | $4.2M | 27 | -7% | N/A | N/A |
What Is Gates Biomanufacturing Facility?
The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus is a 20,000 square ft. FMP compliant facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established in 2015 through partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children's Hospital Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.
keywords:N/AN/A
Total Funding
59
Number of Employees
$9.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gates Biomanufacturing Facility News
Spirulina has been converted into a biomanufacturing platform that offers ... which is located just across the lake from Lumen's facility in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 60 | 20% | N/A |
#2 | $11.3M | 60 | 43% | N/A |
#3 | $12.7M | 62 | -13% | N/A |
#4 | $15.1M | 62 | 7% | N/A |
#5 | $18.1M | 62 | -9% | N/A |